| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1049 |
| Trial ID | ChiCTR-OIN-15007668 |
| Disease | B-Cell Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Open-label, uncontrolled, single-arm pilot study to evaluate cellular immunotherapy using CD19-targeted chimeric antigen receptor engineered T cells in patients with relapsed or refractory CD19+ B cell leukemia |
| Year | 2015 |
| Country | China |
| Company sponsor | Shanghai Changhai Hospital, The Second Military Medical University |
| Cohort 1 | |||||||
|
|||||||